U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170046) titled 'Predictive Value of CEA and ctDNA in Lung Cancer Recurrence' on Sept. 07.
Brief Summary: The study aims to investigate the predictive value of CEA levels for postoperative recurrence in the highly sensitive CEA lung cancer patients and to explore whether the dynamic changes of postoperative CEA and MRD in this population are related.This study was carried out to accurately predict the recurrence time, save the time and cost of changing the intervention strategy, and provide more personalized treatment for patients.
Study Start Date: Sept. 15
Study Type: OBSERVATIONAL
Condition:
Lung Carcinoma
Recruitment Status: NOT_YET_RECRUI...